Association of obestatin with blood pressure in the third trimesters of pregnancy

Peptides

Volumn 30, Issue 9, 2009, Pages 1742-1745

  Ren, An Jing ^a   He, Qian ^b   Shi, Jing Song ^a   Guo, Zhi Fu ^b   Zheng, Xing ^b   Lin, Li ^a   Wang, Yang Kai ^a   Xia, Song Yun ^c   Sun, Li Li ^c   Du, Xin ^c   Sun, Ying ^c   Zhang, Lan Mei ^c   Yuan, Wen Jun ^a,d  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c NAVY GENERAL HOSPITAL   (China)

^d NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Ghrelin; Hypertension; Obestatin; Pregnancy

Indexed keywords

GHRELIN; OBESTATIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; PREGNANCY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY;

ADULT; BLOOD PRESSURE; FEMALE; FETAL BLOOD; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PEPTIDE HORMONES; PREGNANCY; PREGNANCY TRIMESTER, THIRD; YOUNG ADULT;

EID: 67849128519     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.06.016     Document Type: Article

References (29)

1. Anderwald-Stadler M., Krebs M., Promintzer M., Mandl M., Bischof M.G., Nowotny P., et al. Plasma obestatin is lower at fasting and not suppressed by insulin in insulin-resistant humans. Am J Physiol Endocrinol Metab 293 (2007) E1393-E1398
2. Broglio F., Arvat E., Benso A., Gottero C., Muccioli G., Papotti M., et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86 (2001) 5083-5086
3. Chartrel N., Alvear-Perez R., Leprince J., Iturrioz X., Reaux-Le Goazigo A., Audinot V., et al. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science 315 (2007) 766
4. 2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 53 (2004) 3142-3151
5. Gourcerol G., Coskun T., Craft L.S., Mayer J.P., Heiman M.L., Wang L., et al. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity (Silver Spring) 15 (2007) 2643-2652
6. Green B.D., Irwin N., and Flatt P.R. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 28 (2007) 981-987
7. Guo Z.F., Zheng X., Qin Y.W., Hu J.Q., Chen S.P., and Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 92 (2007) 1875-1880
8. Henriques-Coelho T., Correia-Pinto J., Roncon-Albuquerque Jr. R., Baptista M.J., Lourenço A.P., Oliveira S.M., et al. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 287 (2004) H2885-H2890
9. Holst B., Egerod K.L., Schild E., Vickers S.P., Cheetham S., Gerlach L.O., et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 148 (2007) 13-20
10. Iglesias M.J., Salgado A., Piñeiro R., Rodiño B.K., Otero M.F., Grigorian L., et al. Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism. J Endocrinol Invest 30 (2007) 470-476
11. Ikezaki A., Hosoda H., Ito K., Iwama S., Miura N., Matsuoka H., et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 51 (2002) 3408-3411
12. Katugampola S.D., Pallikaros Z., and Davenport A.P. (125I-His(9))-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol 134 (2001) 143-149
13. Lagaud G.J., Young A., Acena A., Morton M.F., Barrett T.D., and Shankley N.P. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem Biophys Res Commun 357 (2007) 264-269
14. Lago R., Gomez R., Dieguez C., Gomez-Reino J.J., Lago F., and Gualillo O. Unlike ghrelin, obestatin does not exert any relevant activity in chondrocytes. Ann Rheum Dis 66 (2007) 1399-1400
15. Makino Y., Hosoda H., Shibata K., Makino I., Kojima M., Kangawa K., et al. Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension 39 (2002) 781-784
16. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280 (2001) R1483-R1487
17. Nunes S., Nogueira-Silva C., Dias E., Moura R.S., and Correia-Pinto J. Ghrelin and obestatin: different role in fetal lung development?. Peptides 29 (2008) 2150-2158
18. Okumura H., Nagaya N., Enomoto M., Nakagawa E., Oya H., and Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 39 (2002) 779-783
19. Pöykkö S.M., Kellokoski E., Hörkkö S., Kauma H., Kesäniemi Y.A., and Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52 (2003) 2546-2553
20. Reimer M.K., Pacini G., and Ahrén B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 144 (2003) 916-921
21. Ren A.J., Guo Z.F., Wang Y.K., Lin L., Zheng X., and Yuan W.J. Obestatin, obesity and diabetes. Peptides 30 (2009) 439-444
22. Ren A.J., Guo Z.F., Wang Y.K., Wang L.G., Wang W.Z., Lin L., et al. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 369 (2008) 969-972
23. Seoane L.M., Al-Massadi O., Pazos Y., Pagotto U., and Casanueva F.F. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats. J Endocrinol Invest 29 (2006) RC13-RC15
24. Solomon C.G., and Seely E.W. Brief review: hypertension in pregnancy, a manifestation of the insulin resistance syndrome?. Hypertension 37 (2001) 232-239
25. Tritos N.A., and Kokkotou E.G. The physiology and potential clinical applications of ghrelin, a novel peptide hormone. Mayo Clin Proc 81 (2006) 653-660
26. Wali A., and Suresh M.S. Maternal morbidity, mortality, and risk assessment. Anesthesiol Clin 26 (2008) 197-230
27. Yamamoto D., Ikeshita N., Daito R., Herningtyas E.H., Toda K., Takahashi K., et al. Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats. Regul Pept 138 (2007) 141-144
28. Zhang J., Zeisler J., Hatch M.C., and Berkowitz G. Epidemiology of pregnancy-induced hypertension. Epidemiol Rev 19 (1997) 218-232
29. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999